Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02650570 · ClinicalTrials.gov registry record

Mitochondrial Respiratory Function in Mammalian Skeletal Muscle

A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.

Terminated
Registry status
1
Enrollment target

NCT02650570: Clinical Trial study, sponsored by The University of Texas Medical Branch, Galveston.

NCT02650570 is a clinical trial that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02650570 was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.

TERMINATED
Registry status
1 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether skeletal muscle mitochondrial function is altered in patients with head and neck cancer compared to healthy controls.

Primary Outcome

Aerobic respiration will be measured from skeletal muscle biopsies of the vastus lateralis using Oroboros O2K high resolution respirometry. The average maximal skeletal muscle oxygen consumption of 10 head and neck cancer subjects will be compared to the average of 10 healthy controls.

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2017-02-14
Est. Completion 2017-03-29

Why NCT02650570 stopped before completion

NCT02650570 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02650570 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02650570 about?

NCT02650570 is a clinical study titled "Mitochondrial Respiratory Function in Mammalian Skeletal Muscle". The purpose of this study is to determine whether skeletal muscle mitochondrial function is altered in patients with head and neck cancer compared to healthy controls.

What is the current status of trial NCT02650570?

This trial is currently terminated. The enrollment target is 1 participants. The study started on 2017-02-14. Estimated completion is 2017-03-29.

Who is sponsoring clinical trial NCT02650570?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02650570, the US trial registry maintained by the National Library of Medicine. NCT02650570 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.